Escitalopram Enhances the Association of Serotonin-1A Autoreceptors to Heteroreceptors in Anxiety Disorders
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Selective serotonin reuptake inhibitors (SSRIs) represent one of the most common treatment options in major depression and anxiety disorders. By blocking the serotonin transporter, SSRIs modulate serotonergic neurotransmission as well as the function of autoreceptors and heteroreceptors. However, treatment-induced changes on a network level primarily remain unknown. Thus, we evaluated the association between serotonin-1A (5-HT 1A) autoreceptors and heteroreceptors before and after SSRIs. Twenty-one patients with anxiety disorders underwent positron emission tomography using [carbonyl-11 C]WAY-100635 before and after 12 weeks of escitalopram treatment; 15 of them completed the study protocol. Additionally, 36 drug-naive healthy controls were measured once. The 5-HT 1A receptor binding potential (BP ND) was quantified for the dorsal raphe nucleus (DRN) using a region-of-interest approach and for the entire brain by calculating parametric maps. Voxel-wise linear regression was applied between DRN autoreceptor and whole-brain heteroreceptor 5-HT 1A BP ND. Consistent with previous observations, healthy subjects showed widespread positive correlations of 5-HT 1A BP ND between autoreceptors and heteroreceptors. Comparing patients before versus after escitalopram treatment revealed enhanced associations of autoreceptor-to-heteroreceptor 5-HT 1A BP ND within the amygdala and hippocampus (R2= 0.21–0.28 vs 0.49–0.81;p< 0.05–0.001). In contrast, no significant SSRI-induced changes were found for correlations of heteroreceptor-to-heteroreceptor 5-HT 1A BP ND between several limbic regions. This interregional approach suggests a treatment-induced reinforcement of the association of 5-HT 1A binding between autoreceptors and heteroreceptors specifically in areas involved in anxiety disorders. These findings provide complementary information about treatment effects on a network level and confirm the central role of the DRN as a prime regulatory area.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands
Innis, R. B., Cunningham, V. J., Delforge, J., Fujita, M., Gjedde, A., Gunn, R. N., Holden, J., Houle, S., Huang, S.-C., Ichise, M., et al. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600493 · Cited by 1,955 · cited 1×
“The 5-HT1A receptor binding potential [BPND (Innis et al., 2007)] was quantified using the multilinear reference tissue model [MRTM2 (Ichise et al., 2003)] for both the DRN ROI and parametric 5-HT1A maps.”
MethodSheline, Y. I., Barch, D. M., Donnelly, J. M., Ollinger, J. M., Snyder, A. Z., & Mintun, M. A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01263-x · Cited by 1,191 · cited 2×
“, 2006) and depression (Sheline et al., 2001) resolved by SSRIs.”
BackgroundMonk, C. S., Telzer, E. H., Mogg, K., Bradley, B. P., Mai, X., Louro, H. M. C., Chen, G., McClure-Tone, E. B., Ernst, M., & Pine, D. S. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.5.568 · Cited by 682 · cited 1×
“On the other hand, patients had lower regression coefficients in the orbitofrontal cortex, a region with decreased functional connectivity to the amygdala in anxiety disorders (Monk et al., 2008), indicating alterations of the entire 5-HT network in the patient group.”
BackgroundHippocampal Neurogenesis: Regulation by Stress and Antidepressants
Dranovsky, A., & Hen, R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.082 · Cited by 663
Antidepressant Drug Treatment Modifies the Neural Processing of Nonconscious Threat Cues
Harmer, C. J., Mackay, C. E., Reid, C. B., Cowen, P. J., & Goodwin, G. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.015 · Cited by 450
Serotonin-1A receptor imaging in recurrent depression: replication and literature review
Drevets, W. C., Thase, M. E., Moses-Kolko, E. L., Price, J., Frank, E., Kupfer, D. J., & Mathis, C. (2007) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2007.06.008 · Cited by 399 · cited 3×
“In healthy subjects, strong correlations of 5-HT1A receptors between the dorsal raphe nucleus (DRN) and projection areas were reported (Rabiner et al., 2002; Borg et al., 2006; Drevets et al., 2007).”
BackgroundArango, V (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00310-4 · Cited by 368
Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain.
Varnäs, K., Halldin, C., & Hall, H. (2004) · Human Brain Mapping · doi:10.1002/hbm.20035 · Cited by 332 · cited 2×
“Here, k2 was calculated from the insula and cerebellum [i.e., receptor-rich and -poor regions (Ichise et al., 2003; Varnas et al., 2004)], both taken from an automated anatomical labeling-based (Tzourio-Mazoyer et al., 2002) ROI atlas (Stein et al., Data are given as mean SD. Alcohol/week, Alcohol…”
MethodThe Effect of Paroxetine on 5-HT2A Receptors in Depression: An [18F]Setoperone PET Imaging Study
Meyer, J. H., Kapur, S., Eisfeld, B., Brown, G. M., Houle, S., DaSilva, J., Wilson, A. A., Rafi-Tari, S., Mayberg, H. S., & Kennedy, S. H. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.1.78 · Cited by 231 · cited 1×
“Furthermore, it seems that a multitude of 5-HT heteroreceptors are also altered by SSRI treatment (Le Poul et al., 2000; Meyer et al., 2001; Burghardt et al., 2007; Spindelegger et al., 2008), indicating adaptive mechanisms within the entire 5-HT system (El Mansari et al., 2005).”
BackgroundMICHELSEN, K., PRICKAERTS, J., & STEINBUSCH, H. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00912-6 · Cited by 196 · cited 6×
“This might be an important issue within treatment (Azmitia, 1999; Michelsen et al., 2008) considering that the serotonin transporter (Frodl et al.”
BackgroundResultInfluentialSerotonin neurons, neuroplasticity, and homeostasis of neural tissue
Azmitia, E. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00022-6 · Cited by 184
Burghardt, N. S., Bush, D. E. A., McEwen, B. S., & LeDoux, J. E. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.11.023 · Cited by 179 · cited 1×
“Furthermore, it seems that a multitude of 5-HT heteroreceptors are also altered by SSRI treatment (Le Poul et al., 2000; Meyer et al., 2001; Burghardt et al., 2007; Spindelegger et al., 2008), indicating adaptive mechanisms within the entire 5-HT system (El Mansari et al., 2005).”
BackgroundEffects of HTR1A C(−1019)G on Amygdala Reactivity and Trait Anxiety
Fakra, E., Hyde, L. W., Gorka, A., Fisher, P. M., Muñoz, K. E., Kimak, M., Halder, I., Ferrell, R. E., Manuck, S. B., & Hariri, A. R. (2009) · Archives of General Psychiatry · doi:10.1001/archpsyc.66.1.33 · Cited by 159
Capacity for 5-HT1A–mediated autoregulation predicts amygdala reactivity
Fisher, P. M., Meltzer, C. C., Ziolko, S. K., Price, J. C., Moses-Kolko, E. L., Berga, S. L., & Hariri, A. R. (2006) · Nature Neuroscience · doi:10.1038/nn1780 · Cited by 156 · cited 1×
“Our findings are in line with previous studies, suggesting that 5-HT1A receptors within the DRN (Czesak et al., 2006; Fisher et al., 2006; Michelsen et al., 2008; Fakra et al., 2009; Richardson-Jones et al., 2010), rather than local heteroreceptors, are the key component for the modulation of…”
ResultKlein, N., Sacher, J., Geiss-Granadia, T., Mossaheb, N., Attarbaschi, T., Lanzenberger, R., Spindelegger, C., Holik, A., Asenbaum, S., Dudczak, R., et al. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0666-y · Cited by 62 · cited 1×
“Based on previous work (Klein et al., 2007), blood samples were collected on the day of the second PET scan 6 h after escitalopram intake.”
MethodSelf-citationThe Neuronatomy of the Serotonergic System
Hornung, J.-P. (2010) · Handbook of Behavioral Neuroscience · doi:10.1016/s1569-7339(10)70071-0 · Cited by 45
Cited by
Kraehenmann, R., Preller, K. H., Scheidegger, M., Pokorny, T., Bosch, O. G., Seifritz, E., & Vollenweider, F. X. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.04.010 · Cited by 323
Lanzenberger, R., Kranz, G. S., Haeusler, D., Akimova, E., Savli, M., Hahn, A., Mitterhauser, M., Spindelegger, C., Philippe, C., Fink, M., et al. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.07.023 · Cited by 139
“…system, involving up- or down-regulations and modifications in the sensitivity of certain 5-HT receptors such as the serotonin-1A (5-HT1A) receptor (Hahn et al., 2010; Hervas et al., 2001; Richardson-Jones et al., 2010; Spindelegger et al., 2009), or the SERT itself (Benmansour et al., 2002; Lau…”
BackgroundSelf-citationZhong, H., Haddjeri, N., & Sánchez, C. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2463-5 · Cited by 105
“Treatment-induced changes of 5-HT1A receptor binding were recently examined using [carbonyl-11C]WAY100635 PET (Hahn et al. 2010).”
InfluentialHahn, A., Haeusler, D., Kraus, C., Höflich, A. S., Kranz, G. S., Baldinger, P., Savli, M., Mitterhauser, M., Wadsak, W., Karanikas, G., et al. (2014) · Human Brain Mapping · doi:10.1002/hbm.22442 · Cited by 66
Self-citationVanicek, T., Kutzelnigg, A., Philippe, C., Sigurdardottir, H. L., James, G. M., Hahn, A., Kranz, G. S., Höflich, A., Kautzky, A., Traub-Weidinger, T., et al. (2017) · Human Brain Mapping · doi:10.1002/hbm.23418 · Cited by 44
Self-citation
Metadata
- Authors
- Hahn, A., Lanzenberger, R., Wadsak, W., Spindelegger, C., Moser, U., Mien, L.-K., Mitterhauser, M., & Kasper, S.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2010-10-27
- Volume
- 30
- Issue
- 43
- Pages
- 14482-14489
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2030462630
- Cited by
- 54
- References
- 16
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.